Coloreyes Eyecare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-07-2024
- Paid Up Capital ₹ 87.70 K
as on 03-07-2024
- Company Age 15 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 49.99%
(FY 2023)
- Profit 46.86%
(FY 2023)
- Ebitda 40.48%
(FY 2023)
- Net Worth 35.67%
(FY 2023)
- Total Assets 30.73%
(FY 2023)
About Coloreyes Eyecare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 87.70 K , as per Ministry of Corporate Affairs (MCA) records.
Harsha Gada and Atul Gada serve as directors at the Company.
- CIN/LLPIN
U85190MH2009PTC189588
- Company No.
189588
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jan 2009
- Date of AGM
12 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Coloreyes Eyecare Private Limited offer?
Coloreyes Eyecare Private Limited offers a wide range of products and services, including Disposable & Other Optical Lenses, Lenses, Contact Lenses, Intraocular Lenses, Contact Lens Accessories, Lens Soaking Cases, Disposable Contact Lens, Colored Contact Lenses, Toric Contact Lenses.
Who are the key members and board of directors at Coloreyes Eyecare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harsha Gada  | Director | 15-Jan-2009 | Current |
| Atul Gada | Director | 15-Jan-2009 | Current |
Financial Performance of Coloreyes Eyecare.
Coloreyes Eyecare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 49.99% increase. The company also saw a substantial improvement in profitability, with a 46.86% increase in profit. The company's net worth Soared by an impressive increase of 35.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Coloreyes Eyecare?
In 2023, Coloreyes Eyecare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Coloreyes Eyecare?
Coloreyes Eyecare has a workforce of 5 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Coloreyes Eyecare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Coloreyes Eyecare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
